Respuesta de los autores

García-Rodríguez, J.A.

doi:10.1016/S0300-2896(02)75287-3

array:22 ["pii" => "S0300289602752873" "issn" => "03002896" "doi" => "10.1016/S0300-2896(02)75287-3" "estado" => "S300" "fechaPublicacion" => "2002-11-01" "aid" => "75287" "copyright" => "Sociedad Española de Neumología y Cirugía Torácica" "copyrightAnyo" => "2002" "documento" => "article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2002;38:547-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4458 "formatos" => array:3 [ "EPUB" => 49 "HTML" => 3993 "PDF" => 416 ] ] "itemAnterior" => array:18 [ "pii" => "S0300289602752861" "issn" => "03002896" "doi" => "10.1016/S0300-2896(02)75286-1" "estado" => "S300" "fechaPublicacion" => "2002-11-01" "aid" => "75286" "copyright" => "Sociedad Española de Neumología y Cirugía Torácica" "documento" => "article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2002;38:547" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4143 "formatos" => array:3 [ "EPUB" => 69 "HTML" => 3505 "PDF" => 569 ] ] "es" => array:7 [ "idiomaDefecto" => true "titulo" => "¿Está justificada la inclusión de levofloxacino en el tratamiento antibiótico empírico de las exacerbaciones de la enfermedad pulmonar obstructiva crónica leve, en pacientes sin comorbilidad y menores de 65 años?" "tienePdf" => "es" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "547" ] ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. Roig, J. Martínez Benazet, J. Casal" "autores" => array:3 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Roig" ] 1 => array:2 [ "nombre" => "J." "apellidos" => "Martínez Benazet" ] 2 => array:2 [ "nombre" => "J." "apellidos" => "Casal" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289602752861?idApp=UINPBA00003Z" "url" => "/03002896/0000003800000011/v1_201307081549/S0300289602752861/v1_201307081549/es/main.assets" ] "es" => array:8 [ "idiomaDefecto" => true "titulo" => "Respuesta de los autores" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "547" "paginaFinal" => "548" ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J.A. García-Rodríguez" "autores" => array:2 [ 0 => array:2 [ "nombre" => "J.A." "apellidos" => "García-Rodríguez" ] 1 => array:1 [ "colaborador" => "Grupo de Consenso de Tratamiento Antimicrobiano de la Bronquitis Crónica" ] ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "Bibliografía" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:10 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Uso de antimicrobianos en la exacerbación de la enfermedad pulmonar obstructiva crónica" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F. Álvarez" 1 => "E. Bouza" 2 => "J.A. García-rodríguez" 3 => "M. Mayer" 4 => "J. Mensa" 5 => "E. Monsó" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Bronconeumol" "fecha" => "2002" "volumen" => "38" "paginaInicial" => "81" "paginaFinal" => "89" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11844440" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P.L. Ho" 1 => "W.S. Tse" 2 => "K.W.T. Tsang" 3 => "T.K. Kwok" 4 => "T.K. Ng" 5 => "V.C.C. Cheng" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1086/319222" "Revista" => array:6 [ "tituloSerie" => "Clin Infect Dis" "fecha" => "2001" "volumen" => "32" "paginaInicial" => "701" "paginaFinal" => "707" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11229837" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P.L. Ho" 1 => "R.W.H. Yung" 2 => "D.N.C. Tsang" 3 => "T.L. Que" 4 => "M. Ho" 5 => "W.H. Seto" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Antimicrob Chemother" "fecha" => "2001" "volumen" => "48" "paginaInicial" => "659" "paginaFinal" => "665" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11679555" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J.M. Blondeau" 1 => "X. Zhao" 2 => "G. Hansen" 3 => "K. Drlica" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Antimicrob Agents Chemother" "fecha" => "2001" "volumen" => "48" "paginaInicial" => "659" "paginaFinal" => "665" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14742232" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "In vitro development of resistance to five quinolones and amoxicillin- clavulanate in Streptococcus pneumoniae" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "T. Davies" 1 => "G. Pankuch" 2 => "B. Dewasse" 3 => "M. Jacobs" 4 => "P. Appelbaum" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Antimicrob Agents Chemother" "fecha" => "1999" "volumen" => "43" "paginaInicial" => "1177" "paginaFinal" => "1182" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10223932" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M. Klepser" 1 => "E. Emst" 2 => "R. Petzold" 3 => "P. Rhomberg" 4 => "G. Doern" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1128/AAC.45.3.673-678.2001" "Revista" => array:6 [ "tituloSerie" => "Antimicrob Agents Chemother" "fecha" => "2001" "volumen" => "45" "paginaInicial" => "673" "paginaFinal" => "678" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11181341" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fluoroquinolone resistant Streptococcus pneumoniae associated with levofloxacin therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Urban" 1 => "N. Rahman" 2 => "X. Zhao" 3 => "N. Mariano" 4 => "S. Segal-Maurer" 5 => "K. Drlica" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1086/323086" "Revista" => array:6 [ "tituloSerie" => "J Infect Dis" "fecha" => "2001" "volumen" => "184" "paginaInicial" => "794" "paginaFinal" => "798" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11517444" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Regional trends in antimicrobial resistance among Clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: Results from the TRUST surveillance program, 1999- 2000" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Thornsberry" 1 => "D. Sahm" 2 => "L. Kelly" 3 => "L. Critchley" 4 => "M. Jones" 5 => "A. Evangelista" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1086/324525" "Revista" => array:7 [ "tituloSerie" => "Clin Infect Dis" "fecha" => "2002" "volumen" => "34" "numero" => "Suppl 1" "paginaInicial" => "S4" "paginaFinal" => "S16" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11810606" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994- 1995" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Brueggeman" 1 => "S. Coffman" 2 => "P. Rhomberg" 3 => "H. Huynh" 4 => "L. Almer" 5 => "A. Nilius" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Antimicrob Agents Chemother" "fecha" => "2002" "volumen" => "46" "paginaInicial" => "680" "paginaFinal" => "688" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11850248" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D. Low" 1 => "J. Azavedo" 2 => "K. Weiss" 3 => "T. Mazulli" 4 => "M. Kuhn" 5 => "D. Church" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Antimicrob Agents Chemother" "fecha" => "2002" "volumen" => "46" "paginaInicial" => "1295" "paginaFinal" => "1301" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11959559" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "es" "url" => "/03002896/0000003800000011/v1_201307081549/S0300289602752873/v1_201307081549/es/main.assets" "Apartado" => array:4 [ "identificador" => "9222" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Letters to the Director / Cartas al Director" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/03002896/0000003800000011/v1_201307081549/S0300289602752873/v1_201307081549/es/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289602752873?idApp=UINPBA00003Z"]

Archivos de Bronconeumología

ISSN: 0300-2896

Archivos de Bronconeumologia is an international journal that publishes original studies whose content is based upon results of research initiatives dealing with several aspects of respiratory medicine including epidemiology, respiratory physiology, pathophysiology of respiratory diseases, clinical management, thoracic surgery, pediatric lung diseases, respiratory critical care, respiratory allergy and basic research. Other types of articles such as editorials, reviews, and different types of letters are also published in the journal. Additionally, the journal expresses the voice of the following scientific societies: the Spanish Respiratory Society of Pneumology and Thoracic Surgery (SEPAR; https://www.separ.es/), the Latin American Thoracic Society (ALAT; https://alatorax.org/), and the Iberian American Association of Thoracic Surgery (AIACT; http://www.aiatorax.com/).

It is a monthly journal in which all manuscripts are sent to peer-review and handled by the editor or an associate editor from the team and the final decision is made on the basis of the comments from the expert reviewers and the editors. The journal is published solely in English. All the published data is composed of novel manuscripts not previously published in any other journal and not being in consideration for publication in any other journal..

The journal is indexed at Science Citation Index Expanded, Medline/Pubmed, Embase and SCOPUS. Access to any published article is possible through the journal's web page as well as from Pubmed, ScienceDirect, and other international databases. Furthermore, the journal is also present in X, Facebook and Linkedin. Manuscripts can be submitted electronically using the following web site: https://www.editorialmanager.com/ARBR/.

Indexed in:

Current Contents/Clinical Medicine, JCR SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, SCOPUS, IBECS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

8.7

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

3.5

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.464

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.482

View more metrics

Open Access Option

Journal Information

Previous article | Next article

Vol. 38. Issue 11.

Pages 547-548 (November 2002)

More article options

Pages 547-548 (November 2002)

DOI: 10.1016/S0300-2896(02)75287-3

Full text access

Respuesta de los autores

Visits

6530

Download PDF

J.A. García-Rodríguez, Grupo de Consenso de Tratamiento Antimicrobiano de la Bronquitis Crónica

This item has received

6530 Visits

Article information

Bibliography

Download PDF

Statistics

Full text is only aviable in PDF

Bibliografía

[1.]

F. Álvarez, E. Bouza, J.A. García-rodríguez, M. Mayer, J. Mensa, E. Monsó, et al.

Uso de antimicrobianos en la exacerbación de la enfermedad pulmonar obstructiva crónica.

Arch Bronconeumol, 38 (2002), pp. 81-89

Medline

[2.]

P.L. Ho, W.S. Tse, K.W.T. Tsang, T.K. Kwok, T.K. Ng, V.C.C. Cheng, et al.

Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study.

Clin Infect Dis, 32 (2001), pp. 701-707

http://dx.doi.org/10.1086/319222 | Medline

[3.]

P.L. Ho, R.W.H. Yung, D.N.C. Tsang, T.L. Que, M. Ho, W.H. Seto, et al.

Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000.

J Antimicrob Chemother, 48 (2001), pp. 659-665

Medline

[4.]

J.M. Blondeau, X. Zhao, G. Hansen, K. Drlica.

Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae.

Antimicrob Agents Chemother, 48 (2001), pp. 659-665

Medline

[5.]

T. Davies, G. Pankuch, B. Dewasse, M. Jacobs, P. Appelbaum.

In vitro development of resistance to five quinolones and amoxicillin- clavulanate in Streptococcus pneumoniae.

Antimicrob Agents Chemother, 43 (1999), pp. 1177-1182

Medline

[6.]

M. Klepser, E. Emst, R. Petzold, P. Rhomberg, G. Doern.

Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model.

Antimicrob Agents Chemother, 45 (2001), pp. 673-678

http://dx.doi.org/10.1128/AAC.45.3.673-678.2001 | Medline

[7.]

C. Urban, N. Rahman, X. Zhao, N. Mariano, S. Segal-Maurer, K. Drlica, et al.

Fluoroquinolone resistant Streptococcus pneumoniae associated with levofloxacin therapy.

J Infect Dis, 184 (2001), pp. 794-798

http://dx.doi.org/10.1086/323086 | Medline

[8.]

C. Thornsberry, D. Sahm, L. Kelly, L. Critchley, M. Jones, A. Evangelista, et al.

Regional trends in antimicrobial resistance among Clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: Results from the TRUST surveillance program, 1999- 2000.

Clin Infect Dis, 34 (2002), pp. S4-S16

http://dx.doi.org/10.1086/324525 | Medline

[9.]

A. Brueggeman, S. Coffman, P. Rhomberg, H. Huynh, L. Almer, A. Nilius, et al.

Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994- 1995.

Antimicrob Agents Chemother, 46 (2002), pp. 680-688

Medline

[10.]

D. Low, J. Azavedo, K. Weiss, T. Mazulli, M. Kuhn, D. Church, et al.

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000.

Antimicrob Agents Chemother, 46 (2002), pp. 1295-1301

Medline